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Background: Stress, depression, and anxiety affect 15 to 25% of pregnant women. However, fewer than 20% of
prenatal care providers assess and treat mental health problems and fewer than 20% of pregnant women seek
mental healthcare. For those who seek treatment, the lack of health system integration and existing barriers
frequently prevent treatment access. Without treatment, poor prenatal mental health can persist for years and
impact future maternal, child, and family well-being.
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Methods/Design: The purpose of this randomized controlled trial is to evaluate the effectiveness of an integrated
process of online psychosocial assessment, referral, and cognitive behavior therapy (CBT) for pregnant women compared
to usual prenatal care (no formal screening or specialized care). The primary outcome is self-reported prenatal depression,
anxiety, and stress symptoms at 6 to 8 weeks postrandomization. Secondary outcomes are postpartum depression,
anxiety, and stress symptoms; self-efficacy; mastery; self-esteem; sleep; relationship quality; coping; resilience; Apgar score;
gestational age; birth weight; maternal-infant attachment; infant behavior and development; parenting stress/
competence; and intervention cost-effectiveness, efficiency, feasibility, and acceptability. Pregnant women are eligible if
they: 1) are <28 weeks gestation; 2) speak/read English; 3) are willing to complete email questionnaires; 4) have no,
low, or moderate psychosocial risk on screening at recruitment; and 5) are eligible for CBT. A sample of 816 women will
be recruited from large, urban primary care clinics and allocation is by computer-generated randomization. Women in
the intervention group will complete an online psychosocial assessment, and those with mild or moderate depression,
anxiety, or stress symptoms then complete six interactive cognitive behavior therapy modules. All women will
complete email questionnaires at 6 to 8 weeks postrandomization and at 3, 6, and 12 months postpartum. Clinic-based
providers and researchers conducting chart abstraction and analysis are blinded. Qualitative interviews with 8 to 10
healthcare providers and 15 to 30 intervention group women will provide data on feasibility and acceptability of the
intervention. Results of this trial will determine the feasibility and effectiveness of an integrated approach to prenatal
mental healthcare and the use of highly accessible computer-based psychosocial assessment and CBT on maternal,
infant, and family-based outcomes.
Trial registration: ClinicalTrials.gov Identifier: NCT01901796
Keywords: psychosocial assessment, online, screening, cognitive behavior therapy, pregnancy, depression, anxiety,
stress, randomized controlled trialBackground
Prenatal mental health problems
Depression, anxiety, and stress are common in pregnancy.
One in four pregnant women experiences symptoms of
depression, stress, or anxiety, with 25% having mild to
moderate symptoms [1]. Without treatment, up to 48%
of women with prenatal anxiety and 70% of those with
prenatal depression [2] continue to experience symptoms
through the postpartum period [3-5] and into their chil-
dren’s early years of life [6-8]. The consequences of poor
perinatal mental health are enduring. Two decades of
well-conducted longitudinal studies demonstrate that even
mild to moderate perinatal distress can have serious ad-
verse effects on mothers and children, including preterm
birth and low birth weight [9], child developmental delay
[7,10,11], and poor child mental health [12,13].The cycle of under detection and under treatment of
prenatal depression, anxiety, and stress
To date, perinatal mental healthcare has focused almost
exclusively on preventing and treating postpartum depres-
sion. This paradigm does not reflect current evidence that
50 to 70% of postpartum anxiety and depression begin
[14] and frequently co-occur [15-17] in pregnancy, nor
does it reflect the enduring effects of poor prenatal mental
health on child health [11,18,19]. Prenatal depression, anx-
iety, and stress are severely under detected and undertreated, and two-thirds of women with substantial symp-
toms remain unidentified by most obstetrical providers
[20,21]. A number of barriers prevent women from seeking
mental healthcare during the perinatal period, including
stigma, fear of being prescribed medication, lack of know-
ledge about whether their symptoms are ‘normal’ or ‘abnor-
mal’, and fear that their concerns will be dismissed [22-24].
However, despite recommendations [25,26] and acceptance
by both healthcare providers [27-30] and women [31-33],
psychosocial assessments are routinely conducted by fewer
than 20% of prenatal care providers [34]. In systems with-
out linkages between assessment, referral, and mental
healthcare, only 18% of pregnant and postpartum women
who are assessed as having mental health problems actually
follow up with a referral that they have been given [35], and
fewer than 15% of those needing care receive some form of
treatment [35,36]. The problem is further complicated by
evidence that most women do not voluntarily disclose men-
tal health concerns [22,37,38] (despite the fact that <4%
refuse provider-initiated assessment) [39,40]. The cycle of
under detection and under treatment is perpetuated by
a ‘catch 22’ where providers do not assess women be-
cause no follow-up services exist [39], and because women
are not assessed, they are not referred and treated. Targe-
ting the individual components of assessment, referral,
or treatment in isolation will not address the need in that
it is not feasible to enhance psychosocial assessment with-
out simultaneously increasing service capacity to receive
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addressed as an integrated process of assessment-referral-
treatment.
Integrated perinatal mental healthcare
Integrated perinatal mental healthcare - the systematic link-
age of assessment, referral, and treatment [41] - has been
recommended by national bodies [25]. Integrated care is a
more efficient approach to primary care management of
depression and anxiety in that it improves access, adher-
ence, and treatment response while being cost-effective
[41-44]. Very few studies have evaluated integrated psy-
chosocial care during the perinatal period [40,45,46]. In
these studies, the high prenatal ‘screening’ rates of 95%
[45] and 62.5% [40] and low refusal rates (<4%) demon-
strate women’s acceptance of routine screening and follow-
up care [40]. The predominant limitations of existing studies
of integrated perinatal mental care (and areas we aim to
improve upon) are: 1) all lacked a comparison group; 2) all
primarily targeted depression without addressing stress
and anxiety; 3) most conducted a minimal feasibility as-
sessment, providing little guidance for improving the inter-
vention or understanding its most effective components; 4)
none evaluated clinical outcomes; 5) none used techno-
logical (for example, web-based) approaches to support in-
tegrated care, although recommended as a key element of
success of integrated care [41]; and 6) none targeted the
most prominent barriers to mental healthcare reported
by providers (for example, lack of time to screen, lack of
screening tools and knowledge regarding their use, lack
of referral mechanisms, unavailable and inaccessible non-
pharmacological therapies) [28,47,48] or by pregnant/
postpartum women (lack of time, preference for working
through their symptoms on their own, stigma associated
with treatment, inability to find/access/afford nonphar-
macologic therapy) [22,24,37]. Together, these limita-
tions highlight the lack of utility that current research
offers in terms of implementing integrated psychosocial
care in clinical settings. There is a need to design and
rigorously evaluate integrated interventions that reduce
barriers and promote access to mental healthcare by
linking standardized psychosocial assessment to effec-
tive mental healthcare.
Standardized psychosocial assessment
Psychosocial assessment comprises the use of a standard-
ized screening tool (for example, Edinburgh Postnatal De-
pression Scale, EPDS) in addition to a holistic assessment
of psychosocial risk factors (for example, Antenatal Risk
Questionnaire, ANRQ-R) [1]. Standardized psychosocial
assessment is feasible [31,35,49,50], improves detection
[51,52] and facilitates triaging of women by symptom se-
verity to ensure that women receive appropriate services
[1]. However, serious resource limitations (for example,lack of time and assessment tools) constrain many pri-
mary care providers from routine assessment of mental
health problems. Computer-based psychosocial assess-
ment conducted in primary care can address such limita-
tions. Evidence exists that patients and providers find the
use of computer-based screening acceptable and feasible
for inquiring about sensitive issues, including prenatal
[53] and postnatal intimate partner violence [54] and
mental health [55,56]. It is also well-suited for busy clinical
settings in that it offers consistency, is resource-sparing,
can be tailored to meet the needs of patients, can be used
with audio/video for low literacy, easily provides a real-
time summary for patients/providers [56,57], achieves
similar rates of disclosure to written- or interview-based
screening, and is preferred by patients due to its perceived
anonymity [56,58,59]. However, a recent systematic review
demonstrated that, on its own, assessment is ineffective in
preventing or treating depression [60] and others have
shown that it does not improve linkage with healthcare in
the form of follow-up assessment or treatment [21,61].
Thus, in order for mental healthcare to be effective, psy-
chosocial assessment must be systematically linked to
treatment.
Cognitive behavioral therapy
Cognitive behavioral therapy (CBT) is a highly effective
treatment for depression and anxiety [62,63]. Since pre-
natal mental health problems are characterized by the
co-occurrence of anxiety and depression [3,16,17], CBT
(including online CBT) is recommended in national guide-
lines as an early intervention for improving maternal-child
outcomes [25]. Randomized controlled trials (RCTs) of
group-based CBT for new mothers [64-68] and pregnant
women [69,70] demonstrate that group CBT is acceptable
and efficacious in reducing risk and symptoms of postpar-
tum depression [64-68].
However, individual- and group-based CBT are fre-
quently inaccessible by pregnant women due to long
wait times (groups often small; number of therapists
limited) and expense (that is, often not covered by health
insurance) [71]. Barriers that are unique to childbearing
families (for example, care of other children) can also hin-
der sustainability of women’s attendance at individual-
and group-based CBT sessions [69,72]. Furthermore, preg-
nant women with mild and moderate symptoms may not
be offered CBT due to resource constraints within the
healthcare system that restrict these limited services to
women with severe symptoms who present with the great-
est need at the current time. Consequently, women with
mild and moderate symptoms are underserved. Without
treatment, there is evidence that 48% of pregnant women
with anxiety and 71% of those with depression continue
to experience symptoms throughout the postpartum
period [2], with as many as one-third of new mothers
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As such, the delay in not treating pregnant women with
mild or moderate symptom severity can lead to substantial
personal, societal, and system costs if their symptoms be-
come chronic or more severe over time [75]. Accessible
and available mental healthcare is a priority for this vul-
nerable population.
Few trials have evaluated CBT in pregnancy [66,69,
70,76,77]. Pilot testing of a prenatal workbook-based CBT
plus telephone coaching by members of our research team
revealed four key findings: 1) pregnant women found the
program acceptable and helpful; 2) they wanted CBT earl-
ier in pregnancy; 3) they wanted an online format; and 4)
they recommended shorter modules [78]. The proposed
trial incorporates these pilot results by using six, 30-
minute modules (versus the original three), delivering the
intervention early in pregnancy (first and second trimes-
ter), and adapting the CBT workbook for online use with-
out the use of a telephone coach.
Online CBT is resource-sparing, clinically and cost-
effective, acceptable [79-82], and accessible [79], and has
been recommended for treatment of anxiety and depres-
sion in primary care [83]. A meta-analysis reported that
online CBT produces moderate to large effects, is as ef-
fective as face-to-face CBT, and has lower attrition rates
(20%) than group-based CBT (40 to 50%) [7,84]. Al-
though not tested in pregnant women, online CBT is an
ideal treatment because it can overcome major deter-
rents to mental healthcare cited by pregnant/postpartum
women, including: long wait times [35], inaccessibility
[35], lack of time [35], finding childcare [24,85], stigma
of attending care [24], and treatment expense [35]. Online
CBT satisfies the majority (93%) of distressed women’s
preference for self-help [24] and should improve aspects
of psychological health (for example, mastery, resilience)
related to poor pregnancy outcomes [86]. Importantly, on-
line CBT can be embedded in current delivery systems,
creating a sustainable approach to effective perinatal men-
tal healthcare. Finally, evidence exists that online CBT and
online CBT plus telephone [87] or email [88] support by a
psychologist are equally efficacious in reducing depression
and promoting adherence. Thus, online CBT, as a stand-
alone intervention, offers a highly cost-effective approach
to mental healthcare that is independent of limited human
resources.
Cost-effectiveness
The cost-effectiveness of integrated perinatal mental
healthcare has not been evaluated [68,89]. However, an
economic evaluation of the cost of treating postpartum
depression demonstrated that public health costs were
twice as high in women with postpartum depression
compared to those without depression [75]. At a preva-
lence rate of 25% among childbearing women, prenatalmental health problems pose a substantial economic and
human resource burden to the healthcare system. How-
ever, widespread implementation of integrated prenatal
mental healthcare (even resource-sparing approaches)
will require a substantial commitment of resources, and
an economic evaluation that considers the individual
(maternal, family, child), local (clinic-and community-
based), and societal implications of early, prenatal inter-
vention compared to usual prenatal care is essential.
Mechanisms of integrated psychosocial care
Integrated prenatal psychosocial care is a complex inter-
vention with several components. We found no studies
that described mechanisms by which prenatal interven-
tion led to improved outcomes [90]. As noted in the
Medical Research Council Framework for Complex In-
terventions, without this knowledge it is difficult to de-
fine which components (for example, program content,
intervention characteristics, method of delivery, assess-
ment approach, referral processes) of an intervention
contribute to its impact and should be replicated in
other settings. Given the need for widely accessible in-
terventions across a diverse spectrum of perinatal care
providers and settings (midwives, nurses/nurse practi-
tioners, family physicians, obstetricians), it is critical to
identify the key components of the integrated interven-
tion that contribute to its effectiveness and facilitate suc-
cessful implementation across settings. In practice, a
pregnant woman would complete the brief online psy-
chosocial assessment while waiting for her clinic ap-
pointment, and her perinatal provider would access
these results in ‘real time’ online (for example, a sum-
mary of psychosocial risk plus question responses). A
decision-making algorithm would provide guidance on
the most appropriate referral options for the provider to
discuss with the woman. Thus, a key aspect of this study
is to understand what aspects of the intervention en-
hance or deter from its implementation success and in-
tegration into routine clinical practice.
Maternal-child outcomes
Strong evidence exists supporting a deleterious, endur-
ing effect of poor prenatal mental health on adverse fetal
[91] and child outcomes [11,18]. Two decades of longi-
tudinal research have demonstrated a clear, independent
association between maternal prenatal distress and
neurodevelopmental outcomes in children [11,18,92]
and adolescents [93]. Although well established in ani-
mal research, early human studies provide evidence of
various biological pathways underlying the link be-
tween prenatal distress and infant/child outcomes, in-
cluding epigenetic mechanisms (that is, fetal DNA
methylation, placental gene expression [91,94]), im-
paired neurogenesis [95], and dysregulation of the fetal
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However, the interplay of influences in the prenatal
and postnatal environments and, in particular, the ex-
tent of the moderating effect of postnatal intervention
on fetal development that has been impacted by pre-
natal depression, anxiety, or stress is largely unknown.
Together, this evidence implies that early prenatal
intervention should be explored as a means to inte-
rrupting the risk of prenatal distress on infant and child
well-being.
Very few studies have evaluated the impact of prenatal
CBT on infant outcomes [76,98], and none have deter-
mined the influence of integrated perinatal mental
healthcare on infant or child well-being, maternal early
caregiving practices, or the maternal-child relationship.
Furthermore, a recent Cochrane review recommended a
RCT to explore the value of integrated prenatal psycho-
social care on maternal-child outcomes [99]. This is an
important line of inquiry, given that symptoms of prenatal
depression, stress, and anxiety tend to continue into the
postnatal period, influencing the quality of the child’s
postnatal environment [7,8,73]. From a healthcare system
and societal perspective, the costs associated with poor
pregnancy outcomes are substantial [11,18,75,100-102],
and treatment options for postpartum mental health [36]
and child developmental problems [103] are severely
limited. Thus, there is a need to evaluate whether early
prenatal intervention can prevent or lessen the risk of
adverse maternal-child outcomes.
The need for a trial
Improvement in perinatal mental healthcare must
begin with an integrated, feasible, effective, and resource-
sparing approach to routine prenatal psychosocial assess-
ment that is seamlessly linked to referral and treatment
across the perinatal period. A systematic review that is
being conducted by our research team on the effective-
ness of non-pharmacological prenatal interventions on
maternal-child outcomes identified four major gaps in
prenatal mental health intervention research involving
the lack of evaluation of: 1) the clinical effectiveness of
integrated psychosocial assessment, referral, and care;
2) the impact of prenatal interventions on prenatal dis-
tress or infant/child outcomes (that is, the main out-
come has primarily been postpartum depression); 3)
factors that contribute to the effect of prenatal interven-
tions (that is, how they worked); and 4) the cost-
effectiveness of prenatal interventions. The current study
aims to address these four gaps by determining the
clinical- and cost-effectiveness of integrated psycho-
social assessment-care-referral compared to usual pre-
natal care, evaluating process outcomes of integrated
psychosocial care, and describing the determinants of
effectiveness of integrated psychosocial care.Research questions
The research objectives, primary and secondary research
questions, and hypotheses associated with the four iden-
tified knowledge gaps are described in Tables 1 and 2.
Methods/Design
Design
The proposed study is a randomized, controlled superior-
ity trial of two parallel groups that includes a prospective
economic evaluation (Figure 1). It has two phases, inclu-
ding: Phase 1 - a randomized controlled trial designed to
evaluate the clinical and cost-effectiveness of an integrated
psychosocial assessment-referral-CBT intervention; and
Phase 2 - a qualitative descriptive component designed to
assess the efficiency, utility, usability, feasibility, acceptabil-
ity, and mechanisms of the intervention (that is, the active
ingredients within the intervention and how they exert
their effect) [104]. The research design best suited for an-
swering questions regarding effectiveness, mechanisms,
and acceptability/feasibility is a design combining a RCT
with a qualitative component [105].
Randomized controlled trial
Setting and recruitment procedures
Recruitment will take place at four primary care clinics
in two large, urban Canadian cities. Two of the clinics
primarily serve an ethnically diverse, socioeconomically
disadvantaged population, with the remaining two clinics
serving a largely middle class, Caucasian population.
Family physicians in these clinics provide complete and
shared prenatal care. Women under complete care re-
ceive all prenatal and delivery care from the family phys-
ician, while those under shared care receive care from a
family physician up to 28 weeks gestation and from an
obstetrician thereafter. Family physicians providing care
at these clinics do not have specialized mental health
training. Eligible women arriving for their prenatal care
appointment will be invited to participate in the study
by clinic administrative staff. Clinic staff will give women
who are interested in study participation a tablet with a
link on the main screen to the consent and question-
naire. A research assistant will be available to answer
questions about the study. Women agreeing to study
participation will complete the electronic consent on a
computer tablet.
Participant eligibility
Pregnant women are eligible to participate if they are:
1) <28 weeks gestation (Note: The upper limit of <28 weeks
allows time to complete six modules and follow-up ques-
tionnaires prior to delivery); 2) able to speak/read English;
3) willing to complete email questionnaires; 4) have no,
low, or moderate psychosocial risk on screening with the
Depression, Anxiety, and Stress Scale at recruitment
Table 1 Primary objective, research question, and hypotheses
Gap objective Research question Testable hypotheses
1 To compare the clinical effectiveness of
integrated psychosocial assessment-care-
referral versus usual prenatal care on prenatal
depression, anxiety, and stress symptoms
What is the effect of integrated, online
psychosocial care delivered in pregnancy to
women with low or moderate psychosocial
risk on the presence and severity of prenatal
depression, anxiety, and stress symptoms at 6
to 8 weeks post-randomization compared to
usual prenatal care?
Presence of symptoms: Compared to women
in the control group, fewer women in the
intervention group will have depression, anxiety,
and stress symptoms (for example, be above the
established cut-off for the DASS21 and EPDS).
Severity of symptoms: Women in the
intervention group will have lower severity of
depression, anxiety, and stress (that is, they will
have lower mean scores on the depression,
anxiety, and stress subscales) compared to those
in the control group.
Kingston et al. Trials 2014, 15:72 Page 6 of 20
http://www.trialsjournal.com/content/15/1/72(Table 3); and 5) are eligible for CBT (Table 3). As in
many trials of CBT [68], women on antidepressants
will not be excluded because the study objective is not
to compare CBT and pharmacological therapy (we plan
a subgroup analysis - see Analysis). We are including
women with ‘no’ symptoms of psychological distress at
the time of recruitment because up to 25% of women
in this group may develop mild or moderate symptoms
of depression, anxiety, or stress during the course of
the trial [106]. In addition, it is important to follow-up
subjects who were not identified as having depression,
anxiety, or stress symptoms on recruitment in order to
understand the implications of false positives (that is,
women identified by screening as positive, but who do
not have symptoms of depression, anxiety, or stress)
and false negatives (that is, women not identified by
screening, but who do have symptoms of depression,
anxiety, or stress) on the cost-effectiveness of the inter-
vention package as a whole.
Prerandomization
All women will complete the Depression, Anxiety, and Stress
Scale (DASS21) and the Edinburgh Postnatal Depression
Scale (EPDS) on recruitment (prerandomization) to deter-
mine study eligibility and provide baseline data on their
mental health status. A computer algorithm designed for
this study (Table 3) will calculate symptom scores of the
DASS21 and EPDS. If a woman’s scores indicate that she
is high risk, a computer-generated message will thank her
for her study participation and indicate that the research
nurse will contact her. Then, the software program will
generate an email to the research nurse who will access the
woman’s online assessment results, telephone the woman
to inform her that she is excluded from the study, provide
feedback on her assessment and, with permission, arrange
appropriate referrals.
Postrandomization
Women in the intervention group will complete the
Antenatal Risk Questionnaire (ANRQ-R). Those who are
‘unsuitable for CBT’ (Table 3) based on the establishedalgorithm using the ANRQ-R and the EPDS will also be ex-
cluded from the trial. They will receive a computer message
thanking them for their participation and informing them
that the research nurse will be contacting them. Within 24
hours, the research nurse will contact these women,
inform them of their ineligibility, provide feedback on the
ANRQ-R, and, with permission, set up a referral with their
healthcare provider. The research nurse will document all
referrals made in a computer-based tracking system devel-
oped and tested through previous screening trials.
As part of the safety protocol, women in the control and
intervention groups assessed as having high symptom scores
at any follow-up assessment based on the DASS21 and
EPDS will be referred by the research nurse to their health-
care provider (Table 3). All participants assessed as high risk
at a follow-up assessment will remain in the trial for the pur-
pose of answering follow-up questionnaires. This is critical
to determine whether the integrated intervention facilitates
linkage to mental healthcare. Given the stability of untreated
mental health symptoms across time [2], we anticipate that
an extremely small proportion (4 to 10%) of participants will
become high risk after initially being assessed as ‘no’ or ‘low
to moderate’ risk at recruitment [14,31].
Randomization and allocation procedures
Once eligible women complete the consent to partici-
pate on the tablet, a simple computer random number
generation algorithm (1:1 allocation ratio) designed for
the study by the Clinical Research Informatics Core at
the Women’s and Children’s Health Research Institute
(University of Alberta) will automatically randomize
women. This will be followed immediately by a computer-
generated message notifying women of their group assign-
ment. The computer randomization ensures that the
research assistant at the clinic is unaware of the participant’s
group assignment prior to allocation, and thus allocation
concealment is maintained.
Sample size estimation
The sample size calculation is based on the primary out-
come of symptoms of depression, anxiety, and stress as
Table 2 Secondary objectives, research questions, and hypotheses
Gap objective Research question Testable hypotheses
1-2 To compare the clinical effectiveness of integrated
psychosocial assessment-care-referral versus usual
prenatal care on postnatal mental health,
psychosocial resources, infant health, and family health
Compared to usual care, what is
the effect of integrated, online
psychosocial care delivered in
pregnancy on:
Compared to women in the control group,
those in the intervention will have significantly:
-decreased presence and severity of depression,




-increased psychosocial resources (self-efficacy,
mastery, self-esteem, coping); improved sleep
quality; and higher relationship quality at 6 to 8
weeks postrandomization and 3, 6, and 12
months postpartum.
…infant health? Infants of women in the intervention group will
have significantly higher: 1) 5-minute Apgar scores,
2) birth weight, 3) gestational age, 4) maternal-
child attachment, and 5) significantly reduced
‘dysfunctional’ infant behavior compared to the
intervention group.
…family health? The intervention group will have significantly
higher parenting competence and partner
relationship quality and significantly lower
parenting stress compared to the control group.
To evaluate process outcomes
of integrated psychosocial care
Is integrated psychosocial care
more efficient, feasible, and
acceptable than usual prenatal care?
Efficiency: Compared to the control group, a
significantly higher percentage of women in the
intervention group will have a psychosocial
assessment and receive treatment. The
intervention group will have significantly lower
percentage of women receiving emergency
mental healthcare compared to the control group.
Feasibility: ≥ 90% of providers and women report
psychosocial assessment is easily done as a component
of routine prenatal care, ≥ 95% of intervention group
women will access cognitive behavior therapy modules
(CBT) within 2 weeks of psychosocial assessment, ≥ 80%
of intervention group will access the CBT modules every
1-2 weeks, ≥75% intervention group will complete all
CBT exercises, and intervention group will complete 80-
100% modules within 6 to 8 weeks.
Acceptability: ≥ 90% of intervention group women
and providers will report tablet-based psychosocial as-
sessment during prenatal care acceptable, > 90%
women will report that they could provide ‘honest’ re-
sponses, and ≥ 90% of intervention group women and
providers will find the CBT modules acceptable.
Utility: ≥ 85% of intervention group will report that
the CBT homework exercises were useful, and ≥ 90%
of intervention group will report each module as
useful.
Usability: ≥ 90% of intervention group will report that
the exercises and modules were clear, easy to
understand, and easy to navigate around.
(Note. Targets are based on meta-analyses of
adherence and satisfaction rates [44]).
3 To describe mechanisms of integrated care What are the mediators and
moderators of the intervention
effect?
Psychosocial resources (self-efficacy, mastery, self-
esteem, coping), sleep, and relationship quality will
mediate the impact of the intervention on maternal,
child, and family outcomes; and participant
characteristics will moderate the effect (for example,
demographics, use of antidepressants).
4 To compare the cost-effectiveness of integrated
psychosocial care compared to usual care
Is the integrated psychosocial care
model cost-effective when
compared to usual prenatal care?
The expected incremental cost effectiveness of
integrated psychosocial assessment, referral, and
targeted cognitive behavioral therapy is cost
effective at values of health considered acceptable
in the Canadian healthcare system.
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Figure 1 CONSORT Trial Flow Diagram. DASS21, Depression, Anxiety, Stress Scale; EPDS, Edinburgh Postnatal Depression Scale.
Kingston et al. Trials 2014, 15:72 Page 8 of 20
http://www.trialsjournal.com/content/15/1/72measured by the Depression, Anxiety, and Stress sub-
scales of the DASS21 [107]. We calculated the sample
size required to test the minimum clinically important
difference in each subscale and selected the highest one
for the final sample size. Based on DASS21 data col-
lected as part of Australia’s national perinatal mental
health initiative, standard deviations for the depression,
anxiety, and stress subscales in pregnant women are 5.4,
10.2, and 8.6 [108]. To determine the minimal clinically
important difference, we used Milgrom et al.’s [66] ap-
proach for calculating the difference in scores on each
subscale that would shift a woman one level of severity -
the minimal, reasonable expectation for an effective the-
rapy. For example, the DASS21 manual ‘categorizes’
women as having normal, mild, moderate, severe, and ex-
tremely severe symptoms of depression, anxiety, and stress
[107]. To shift women from ‘mid-range’ moderate to mild
severity on the depression, anxiety, and stress subscaleswould require a reduction of 4 points in each subscale.
Therefore, based on the sample size formula for compari-
son of two means (2-tailed) at a significance level of 5%
(1.96), a power of 80% (.84), and a minimally clinically im-
portant difference of 4 points, 204 women with mild to
moderate symptoms of psychological distress are required
in the trial (Table 4).
Based on a 25% prevalence rate of low-moderate pre-
natal psychological distress [1,31], a final sample size of
816 eligible women (408 per group) would be needed.
This corresponds to a moderate effect size (d = 0.4 to 0.7)
across subscales, which is consistent with a meta-analysis
of effect sizes of online CBT [84]. This sample size is
also adequate to conduct structural equation modeling
to address secondary objectives related to mechanisms
underlying the impact of the intervention. Kline rec-
ommends a minimum sample size of 200 for complex
structural equation models or 10 to 20 cases per level
Table 3 Criteria for ‘high risk’ and referral to physician
Based on baseline DASS21/EPDS Based on ‘unsuitability’ for CBT (intervention group)
Women with ‘severe’ or ‘extremely severe’ psychological distress
based on one or more of the following criteria:
Women in intervention group with three or more of the following criteria:
1. Depression subscale ≥21 and/or 1. ANRQ-R positive for childhood emotional neglect, childhood emotional
abuse, or childhood sexual or physical abuse and/or
2. Anxiety subscale ≥15 and/or 2. ANRQ-R positive for multiple major stressors (for example, major financial is
sues, bereavement, or separation)
3. Stress subscale ≥26 3. Current substance use or domestic violence
4. EPDS positive Q10 (1, 2, or 3) 4. EPDS positive Q10 or total EPDS score >15
ANRQ-R, Antenatal Risk Questionnaire-Revised; CBT, cognitive behavior therapy; DASS21, Depression, Anxiety, Stress Scale 21; EPDS, Edinburgh Postnatal
Depression Scale.
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816 participants is adequate to address primary and
secondary research questions. Accounting for a partici-
pation rate of 50% based on previous studies of CBT
in pregnant women [110], the exclusion of 15%
of women who do not meet study criteria (5% high
psychosocial risk [1,31], 10% non-English speaking
women), a conservative attrition rate of 35% based on
previous studies of prenatal CBT [84], and a 5% loss-
to-follow-up (no data reported but our questionnaire
follow-up through email should be largely unaffected
by change in residence etcetera), 1,673 women would
need to be invited to participate in the study to achieve
the final sample size. Given that the number of new
pregnant patients across the four recruitment sites is
120 per month, the duration of recruitment is antici-
pated to be 14 months.Intervention
The intervention consists of usual prenatal care plus an
integrated intervention comprising: 1) online psycho-
social assessment, 2) referral, and 3) online CBT.Table 4 Sample size estimation
N = 2(0.84 + 1.96)2 * (σ/§)2
σ = standard deviation of the primary outcome (Depression, Anxiety,
Stress subscales of DASS21)
§ =minimal clinically important difference
Depression subscale Anxiety subscale Stress subscale
N = 2(0.84 + 1.96)2 *
(σ/§)2
N = 2(0.84 + 1.96)2 *
(σ/§)2
N = 2(0.84 + 1.96)2 *
(σ/§)2
N = 2(0.84 + 1.96)2 *
(5.4/4)2
N = 2(0.84 + 1.96)2 *
(10.2/4)2
N = 2(0.84 + 1.96)2 *
(8.6/4)2
N = 28.6 per group N = 102 per groupa N = 72.5 per group
aLargest sample size per group = 102. Total sample of women with mild to
moderate psychological distress = 204. Based on a prevalence rate of 25% of
low-moderate symptoms in pregnant women, a final sample size of 816
(408 per group) will be required (204/N = 25/100).Online psychosocial assessment
Following randomization to the intervention group, par-
ticipants will begin the intervention by self-completing
the psychosocial assessment (ANRQ-R) on the tablet
while waiting for their prenatal appointment. Developed
and psychometrically tested by one of our team mem-
bers [31] the ANRQ-R was designed to be embedded
within an integrated system of assessment-referral-care
to identify psychosocial risk factors associated with poor
mental health outcomes in pregnant women. A system
for categorizing level of risk and tailored referral has
been devised to enable triaging of women to appropriate
services (including CBT) [1]. Its recommended use
alongside the EPDS permits identification of psycho-
social risk and current symptoms (past 7 days). Both in-
struments can be completed together in less than 10
minutes. The ANRQ-R has high levels of acceptability
and satisfactory psychometric properties (sensitivity 0.62;
specificity 0.64) [1,31], comparable to other commonly
used self-report depression/anxiety tools. The EPDS is a
widely used 10-item self-report depression scale used to
detect depression symptoms during the previous 7 days
[111]. Psychometrically validated for use in pregnant and
postpartum women [112], testing revealed sound psy-
chometric properties (sensitivity 86.7%; specificity 78%;
positive predictive value 74%, α = .87) [111]. An intro-
ductory section to the ANRQ-R describes the import-
ance of routine psychosocial assessment and how it will
be used as an initial step to help women with emotional
health concerns.
Referral
Once women in the intervention group submit their
psychosocial assessment, a software program developed
for this study will use a scoring algorithm to determine
whether the intervention group participant meets
criteria for CBT based on ANRQ-R and EPDS scores
(see Participant Eligibility). A trained research nurse will re-
ceive notification of participant enrolment and telephone
all women in the intervention group within 48 hours
to review the results of the psychosocial assessment. A
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sults; however, this review will be tailored to participants’
specific needs in response to their questions and concerns.
The research nurse will refer women who meet criteria to
the CBT modules (for example, give them the password,
web-link, and instructions on accessing and completing
the modules).
Women in the intervention group who were assessed as
‘no’ risk on recruitment, but who convert to low or mod-
erate risk at the 6 to 8 week postrandomization follow-up
will also be referred to the CBT modules. In this case, the
research nurse will receive an automatically generated
email and will follow-up with a discussion on symptom
scores and referral to the CBT modules. Including women
in the study with a gestational age of less than 28 weeks
gives sufficient time for women detected at 6 to 8 weeks
postrandomization to complete the intervention during
pregnancy.
Online cognitive behavior therapy
Eligible women in the intervention group will be asked to
complete the six, 30-minute online, interactive CBT mod-
ules over 6 to 8 weeks [113,114]. Four [77] to six [69]
CBT sessions have been found to effectively reduce de-
pression symptoms. The topics of the modules are: 1) tak-
ing stock; 2) identifying and labeling emotional health
concerns; 3) changing distorted thinking; 4) understanding
and changing actions, responses, and behavior; 5) relax-
ation; and 6) developing and maintaining a plan. Each
module has interactive homework assignments that
women complete online. Each assignment has one to four
options and women select the one (or more) that best
suits their needs. Completion of the homework is required
before progression in the modules can occur. The mod-
ules utilize pregnancy-relevant scenarios and these are
used as the basis of examples in the homework assign-
ments. The online delivery allows women to set their own
pace by completing the modules at a time and location
that is most convenient and ensures standardization of the
intervention. Women will access the modules using a
username and password, and content that women provide
in the homework assignments is accessible only by them.
Comparator: usual prenatal care
The control group will receive usual prenatal care. Usual
prenatal care at the study sites does not include routine
psychosocial assessment or follow-up of psychosocial
concerns. Given that this typifies standard prenatal care
in the majority of perinatal settings in North America,
‘usual prenatal care’ is the best comparator. All women in
the control group will be followed up at 6 to 8 weeks post-
randomization and at 3, 6, and 12 months postpartum
using the same questionnaires as those delivered to the
intervention group. An automatic email will be generatedto the research nurse for women in the control group who
convert from no, low, or moderate risk to high risk at the
6 to 8 week postrandomization follow-up. The research
nurse will contact these women and, with permission,
set up a referral to their healthcare provider. These
women will continue in the trial to complete all follow-
up questionnaires.
Definition and measurement of outcomes
Primary outcome The primary outcome is the presence
and severity of current prenatal depression, anxiety,
and stress symptoms as measured by the DASS21 [107]
(Table 5). The DASS21 has been widely used and psycho-
metrically tested; it distinguishes well between symptoms of
depression, anxiety, and stress in clinical and non-clinical
populations [107,115,116]. It is used in clinical settings to
screen pregnant and postpartum women for presence and
severity of current symptoms of depression, anxiety, and
stress [108,117]. The DASS21 has good psychometric prop-
erties with Cronbach α’s of 0.91, 0.80, and 0.84 respectively
for depression, anxiety, and stress subscales [116]. High
correlations with other standardized depression, stress, and
anxiety measures (for example, Beck Depression Inventory,
State-Trait Anxiety) and clinical assessments demonstrate
its validity [118,119].
The presence of symptoms of prenatal depression, anxiety,
and stress is measured as the proportion of women scoring
above established cut-offs (>10; >8; >15, respectively) [107].
Severity of symptoms is measured by the mean depression,
anxiety, and stress scores. Ranges of scores corresponding
to symptom severity levels of ‘no’, ‘mild’, ‘moderate’, and
‘severe’ are also well-established through psychometric
testing: depression (none 0-9; mild 10-13; moderate 14-20;
severe > 21); anxiety (none 0-7; mild 8-9; moderate 10-14;
severe > 15); and stress (none 0-14; mild 15-18; moderate
19-25; severe >26) [107].
Secondary outcomes All secondary outcomes and their
measures are described in Table 5. The secondary clin-
ical outcomes are: presence and severity of symptoms of
postpartum depression, anxiety, and stress [107]; prenatal
and postnatal self-efficacy [123], social support [121],
sense of mastery [122], self-esteem [124], sleep [125,126],
relationship quality [7,129], coping [130], and resilience
[91]; 5-minute Apgar score; gestational age; birth weight;
maternal-infant attachment [131]; infant behavior [132];
infant development [91,133]; and parenting stress/compe-
tence [127,128] (Table 5). These outcomes were selected
because of their association with maternal depression,
anxiety, and stress and their potential modifiability by the
intervention. Other secondary process outcomes related
to the intervention include its: cost-effectiveness; effi-
ciency; utility; usability; acceptability, and mediators and
moderators of effect (Table 5).
Table 5 Data collection schedule and measures
Variable (Measure) Timing of measures










Demographics (education, income, maternal age at recruitment,
ethnicity) (Items from Maternity Experiences Survey, bMES [120])
X
Obstetric and medical history (parity, chronic and pregnancy
complications, type of delivery, weight - pre-pregnancy, delivery, 6
weeks postpartum) (Items from MES)
X X
Mental health history (history of depression, anxiety, stress; age of
onset of previous episodes of mental health problems) (Items from
MES)
X
Pharmacologic therapy for depression/anxiety (past; current) (Items
from Canadian Community Health Survey, CCHS)
X X X X X
Social support (Interpersonal Support Evaluation List, ISEL [121]) X X X X X
Prenatal depression, anxiety, stress symptoms (Depression, Anxiety,
and Stress Scale, DASS-21 [107] - presence (percent above cut-off
point) and severity (mean score, standard deviation)
X X
Postnatal depression, anxiety, stress
symptoms (Depression, Anxiety, and Stress Scale, DASS-21 [107] -
presence (percent above cut-off point) and severity (mean score,
standard deviation)
X X X X X
aPsychosocial assessment (Antenatal Risk Questionnaire-Revised,
ANRQ-R; includes substance use and violence) [1,31]
X X X X X
Depression (Edinburgh Postnatal Depression Scale, EPDS) [111] X X X X X
aANRQ-R acceptability X
Mastery (Pearlin’s Mastery Scale) [122] X X X X X
Self-efficacy (Generalized Self-Efficacy Scale) [123] X X X X X
Self-esteem [124] X X X X X
Resilience (Connor-Davidson Resilience Scale) [91] X X X X X
Sleep (Pittsburgh Sleep Quality Index) [125,126] X X X X X
Parenting competence (Parenting Sense of
Competence Scale, PSCS; subscales Efficacy, Interest, Satisfaction) [127]
X X X
Parenting stress (Parental Stress Scale) [128] X X X
Relationship quality and adjustment (Dyadic Adjustment Scale, DAS-7)
[7,129]
X X X X X
Coping (Brief Cope) [130] X X X X X
Maternal-infant attachment (Condon and Corkindale) [131] X X X
Infant behavior (Infant Behavior Questionnaire) [132] X X X
Infant development (Ages and Stages Questionnaire,
3rd edition, ASQ-3; The Baby Pediatric Symptom
Checklist for Social/Emotional Screening) [91,133]
X X X
Birth weight (medical record) X
Gestational age (medical record) X
5-minute Apgar score (medical record) X
Other factors related to infant outcomes: feeding method (medical
record and parent-report); neonatal/infant health (medical record and
parent-report) (Parent report items from the All Our Babies birth
cohort studyc)
X X X
Patient diaries [134] (For economic analysis - including health service
use, medication use, productivity loss, personal cost)
X X X X X
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Table 5 Data collection schedule and measures (Continued)
Quality of life (For economic analysis - SF-36,SF-6D to calculate QALY)
[135]
X X X X X
Efficiency of intervention (percent of women with psychosocial
assessment, referral, and care in IG versus CG; self-report and medical
record)
X X X
Utility of intervention (one question asked at the end of each
cognitive behavior therapy (CBT) homework exercise: This exercise was
useful to me with four response options of I strongly agree, I
somewhat agree, I somewhat disagree, I strongly agree; one question
asked at the end of each CBT module: The information in this module
was useful to me with same response options)
X
Usability of intervention (one question asked at the end of each CBT
homework exercise: This exercise was clear and easy to understand with
response options; 2 questions asked at the end of each module: 1) The
information in this module was clear and easy to understand; 2) It was easy
to work through the module (for example, it was easy for me to get from one
part to the other, easy to find what I needed) with same response options)
X
Acceptability: Tablet-based psychosocial assessment (one question at
end of completing ANRQ-R: I would recommend a tablet-based ap-
proach to asking about emotional health to a pregnant friend with four
response options of I strongly agree, I somewhat agree, I somewhat
disagree, I strongly agree)
X
Acceptability: CBT (one question at end of each CBT module: I would
recommend this module to a pregnant friend who was struggling with
stress, depression, or anxiety with 4 response options of I strongly
agree, I somewhat agree, I somewhat disagree, I strongly agree)
X
Overall assessment (two open-ended questions at the end of every
CBT module: 1) The thing I liked most about this module was….; 2) The
thing I liked least about this module was….)
X
Log of interactions with participants (completed by research nurse) X X X
PHASE 2
Efficiency (Providers’ views of the efficiency of the process of clinic-
based online psychosocial assessment)
X
Utility (Women’s views of how useful the modules in were in meeting
their needs)
Usability (Women’s views of how easy/difficult the modules were to
navigate)
X
Feasibility (providers’ views of feasibility of conducting integrated
intervention in their setting; women’s views of the feasibility of doing
the modules; Google Analytics for example, percent of women
accessing CBT within 2 weeks postassessment; percent of women
accessing each CBT module within 1 to 2 weeks; percent completion
of all six CBT modules; percent completion of CBT modules within 8
weeks)
X
Acceptability (women’s and providers’ views of acceptability/ability to
promote disclosure)
X
Mechanisms (women’s views of why and how the intervention did/




bThe Maternity Experiences Survey (MES) is a national survey designed and administered by the Public Health Agency of Canada and Statistics Canada. The survey
was designed through an exhaustive process involving discussion, consultation, literature reviews, focus group testing, and two pilot studies [120].
cThe ‘All Our Babies Birth Cohort’ study is a pregnancy birth cohort in Alberta, Canada. Details of the study methodology and design have been previously
published [136].
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Procedures The five data collection points for all study
participants are: recruitment; 6 to 8 weeks postrandomi-
zation; and 3, 6, and 12 months postpartum (Table 6).
On recruitment, all consent and baseline data arecollected via a computer tablet while women wait for their
prenatal appointment. Follow-up questionnaires will be
completed online. Participants will receive an email with a
password and link to the questionnaire on the project
website (www.yourhope.ca). Retention will be enhanced
Table 6 Schedule of enrollment, interventions, and assessments
Enrollment Allocation CBT Suitability Post-randomization
TIME POINT -t1 0 0 T1
(Baseline)














Determination of suitability for



















Utility, usability, acceptability of
intervention
X
Phase 2: Qualitative interviews X X X
ANRQ-R, Antenatal Risk Questionnaire; CBT, cognitive behavior therapy; DASS21, Depression, Anxiety, Stress Scale; EPDS, Edinburgh Postnatal Depression Scale.
aBaseline variables: demographics; history-obstetric, medical, mental health diagnosis and treatment; social support; mastery; self-efficacy; resilience; sleep; partner
relationship; coping.
bSecondary outcomes - maternal: mental health treatment; social support; mastery; self-efficacy; resilience; sleep; partner relationship; coping; mental health
service utilization.
cSecondary outcomes - maternal and infant: mental health treatment; social support; mastery; self-efficacy; resilience; sleep; partner relationship; coping; parenting
competence; parenting stress; maternal-infant attachment; infant behavior; infant development; gestational age; birth weight; 5-minute Apgar Score; mental health
service utilization; quality of life.
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not completed the questionnaires within 1 week will re-
ceive computer-generated email/smartphone reminders
at 1, 3, 7, 10, and 14 weeks by Checkbox Survey Server.
We will track reasons for nonadherence (for example,
lost to follow-up).
Management No data are stored on the tablets; rather,
when women ‘submit’ their information it is sent to a
secure server housed in the Faculty of Medicine &
Dentistry’s Data Centre (University of Alberta). Data
transfer between the tablet and server will be encrypted.
Follow-up questionnaires will be distributed and submit-
ted via email that is also encrypted. All processes involving
electronic data capture and storage are managed by the
Women’s and Children’s Health Research Institute In-
formatics Core at the University of Alberta. Once data col-
lection has been completed, de-identified data will be
stored in the Health Research Data Repository at theUniversity of Alberta. Access to the Repository is re-
stricted to research team members conducting analyses.
Attrition, adherence, fidelity, and concomitant care
Attrition rates in online CBT are roughly half those [84]
of group-based CBT [68]. We will compare attrition
rates in the intervention and control groups and conduct
telephone interviews with women who drop out of the
intervention group to assess reasons. Adherence, that is,
the extent to which women complete the psychosocial
assessment and CBT components, will be documented
through Google Analytics and application specific ana-
lytics developed for this study (for example, number
modules completed, length of time to complete modules,
etcetera). As part of the qualitative descriptive compo-
nent we will seek women’s opinions about aspects of the
psychosocial assessment that were challenging and fea-
tures of the CBT modules that impacted their ability,
need, or desire to complete them.
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group, the research nurse will outline the importance of
regular progress through the module homework and the
benefit of completing all modules when she provides in-
structions on how to access the modules. A second key
strategy to optimize adherence is the use of email and
smartphone reminders to complete the CBT modules if
women have been inactive on the site for more than 2
weeks. These reminders will automatically be generated
by the software program.
The online format of the intervention preserves its fidel-
ity (that is, consistency in its components and delivery) and
thus enhances external validity. To limit co-intervention
bias, all women will be discouraged from participating in
other self-referred forms of non-pharmacological mental
healthcare. However, if the blinded physician detects symp-
toms of psychological distress in the course of usual
prenatal care, the study participant may initiate the rec-
ommended pharmacological or non-pharmacological
therapy. Follow-up questionnaires will ask women to
disclose any pharmacological or non-pharmacological
therapy that they have begun and this additional inter-
vention will be accounted for in the analyses.
Minimizing the risk of bias
Blinding We will ask women not to share their study
involvement with their physician in order to maintain
physician blinding and limit the possibility that the phys-
ician would change his/her approach to ‘usual prenatal
care’. If physicians show greater vigilance in their routine
prenatal care as a result of clinic trial involvement, we
anticipate that both control and intervention groups
would be affected. It is not possible to blind participants
due to the nature of the intervention. Women will self-
report on all outcomes with the exception of birth weight,
gestational age, neonatal health and feeding method at
birth, and Apgar scores. These data will be abstracted
from the medical record by a research assistant blinded to
group allocation, thereby limiting ascertainment bias.
Given that current mental health may impact women’s
perceptions of infant development and maternal-infant at-
tachment, we will control for current mental health when
analyzing these outcomes (for example, DASS21 assesses
symptoms of depression, anxiety, stress past 7 days). Re-
searchers will be blinded throughout the trial. Finally, the
database used for analysis will not include women’s alloca-
tion assignment, and therefore the researcher and assist-
ant conducting data analyses will be unaware of group
assignment.
Selection bias Selection bias will be limited by consecu-
tive recruitment of women that allows every eligible
woman to have an opportunity to participate in the study;
however, selection bias will still be a potential factoraffecting external validity given the non-random selection
of our study sites and the exclusion of non-English speak-
ing women. We also aim to limit threats to internal valid-
ity by reducing attrition through the design of the easily
accessible, online CBT program rather than a group pro-
gram. Information bias is minimized due to the use of
standardized tools and prospective data collection. Co-
intervention may occur if women in the intervention
group seek additional formal or informal help for de-
pression/anxiety symptoms in addition to the interven-
tion. We will measure additional service use to parse
out the independent effect of the CBT component (for
example, subgroup analysis) and to inform the eco-
nomic analysis. Contamination will be minimized by: 1)
having all eligible women ‘do the same thing’ in the clinic
(for example, use computer tablet); 2) delivering the inter-
vention away from the physician office; 3) encouraging
women not to discuss trial involvement with other pa-
tients in the clinic; and 4) ensuring that only women allo-
cated to the intervention group access the CBT modules
by having a password-protected entry.
Ethics considerations
The study protocol was approved by the Human Research
Ethics Board at the University of Alberta. Following elec-
tronic consent, all women and sites will receive an emailed
copy of the Participant Information Letter and Consent.
Safety protocol
Several strategies have been implemented to monitor
both intervention and control group women’s psycho-
social risk and ensure their safety throughout the trial.
Intervention group Mental health crisis contact infor-
mation is visible on a sidebar of the online CBT modules
and remains accessible at all times. The sidebar also con-
tains a statement encouraging women who feel worse
than when they started the intervention to contact the
research team’s mental health nurse through a dedicated
email link. This message indicates that research nurse
will contact the woman within 24 hours. An algorithm
will guide the research nurse’s decisions regarding the
level of help or referral (for example, to a mental health
expert on the research team or woman’s physician) that is
provided. Women who were assessed as ‘no’ risk but con-
vert to low or moderate risk at the 6- to 8-week postrando-
mization follow-up will be contacted by the research nurse
and referred to the CBT modules (see Referral). All interac-
tions and decisions will be documented in a computer-
based tracking system by the research nurse. The mental
health therapists and psychiatrists on the team are available
for consultation.
At the end of each CBT module, women will complete
question 10 of the EPDS (self-harm thoughts over past
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(Q10 = 1, 2, or 3) will generate an automatic ‘pop-up’
message with crisis contact information for the woman’s
immediate use and an email to the research nurse. The re-
search nurse will contact the woman within 24 hours to
assess further and ensure that the woman is receiving help
from a healthcare provider. If not, the research nurse will
link her to additional resources as guided by an algorithm
devised for this study. A 4% affirmative response rate to
Q10 of the EPDS has been reported [14]. These women
will continue in the trial. A log of interactions and deci-
sions will be maintained by the research nurse.
Intervention and control group For women who con-
vert from no, low or moderate risk (on recruitment) to
‘high’ risk (based on DASS21 and EPDS scores) at any
follow-up point, an automatic email will be generated to
the research nurse. The research nurse will contact the
woman, describe her assessment results, and create a re-
ferral to her healthcare provider with her permission.
These women will remain in the trial to complete the
follow-up questionnaires. All interactions and decisions
will be documented in a log by the research nurse.
Training The mental health research nurse will attend a
4-hour training session conducted by mental health experts
on the research team regarding the use of the algorithm to
guide decision-making and referrals, the availability of local
mental health services, and techniques for assisting women
in crisis, including domestic violence. The research nurse
will collaborate with the perinatal provider and relevant
local agencies to provide support.
Analyses
Effectiveness of intervention We will use descriptive
data (frequencies and 95% confidence intervals, CI; means
and standard deviation, SD) to describe the sample. We
will test for differences in baseline characteristics using t-
tests (means) and chi-squared tests (%). We will assess dif-
ferences proportions and mean scores of primary and sec-
ondary outcomes at each follow-up point using chi-square
and t-tests, respectively. We will use an intention-to-treat
analysis. We will also use multivariable logistic regression
to determine predictors of outcomes and report relative
risks and 95% CIs. Multivariable regression models will be
built using variables that are associated with outcomes at
P <0.10 on unadjusted analyses. Primary analyses will use
a type I error of 5% as a criterion for statistical signifi-
cance, while a more stringent alpha of 0.01 will be used
for secondary outcomes to account for multiple testing.
Because women will be starting the intervention at dif-
ferent points in pregnancy we will control for gestation.
We plan to conduct an exploratory analysis using strati-
fied analyses to explore a priori subgroup differences ofintervention effect by: (a) number CBT sessions, (b)
antidepressant use, (c) symptom clusters, (d) severity of
symptoms of psychological distress (DASS21), (e) add-
itional mental health service use, (f) participant character-
istics, (g) mental health history, and (h) gestation at time
of recruitment. We expect the volume of missing ques-
tionnaire data to be low due to the design of the electronic
data capture that requires data fields to be populated prior
to progressing to subsequent questions. As such, we do
not plan to conduct imputation of missing data.
Efficiency, utility, usability, and acceptability of
intervention In addition to analyzing the qualitative data
that are gathered through Phase 2 interviews, we will use
descriptive statistics (frequencies, proportions, means,
standard deviations) to describe the efficiency of the inter-
vention (for example, percent of women with psychosocial
assessment, referral, and care in intervention group versus
control group) and intervention group women’s percep-
tions of the utility (for example, rated usefulness of exer-
cises and module), usability (for example, rated ease of use
of exercises and module), and acceptability (rated willing-
ness to recommend intervention) of the intervention
(Table 3). We will also identify the main predictors of
these intervention features through multivariable logistic
regression and will include variables such as demographic
characteristics (including parity), comfort with computer
technology, current DASS21 scores, history of mental
health problems, and use of ancillary mental health ser-
vices. All independent variables that are related to each
feature at P <0.10 will meet criteria for entry to the multi-
variable models. Adjusted odds ratios and 95% confidence
intervals will be reported.
Mechanisms of effect of intervention We will deter-
mine factors that influence acceptability and uptake of
the intervention using multivariable logistic regression,
as adjusted relative risks and 95% CIs. As a preliminary
step to model building, we will conduct unadjusted lo-
gistic regressions with the criterion for entry into the
final multivariable model being P <0.05. We will use
structural equation modeling (SEM) to describe the direct
and mediated effects of the intervention on outcomes.
SEM is highly useful for describing complex pathways be-
tween an intervention and outcomes that can inform how
the intervention has its effect. Consistent with rigorous
SEM methodology [109], we will develop a priori models.
We will analyze and refine the fit of the model based on
recommended model fit indices (for example, model chi-
square, Bentler comparative fit index) and theoretical
plausibility of the pathways [109]. We will use maximum
likelihood estimation for estimation of means, variances,
and covariances in order to retain records with missing
data in our analysis. We will also analyze qualitative data
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and how the intervention did/did not improve outcomes
(Table 3).
Cost-effectiveness of intervention The economic
evaluation will be a within-trial cost effectiveness ana-
lysis comparing the integrated intervention ‘package’
with usual prenatal care. The perspective of the primary
analysis will be that of the health and social care budget.
A secondary analysis will adopt a societal perspective in-
corporating personal costs and productivity costs in
addition to the health and social costs associated with the
delivery of the intervention (for example, cost of equip-
ment, salary of research nurse and clinic staff) and subse-
quent service utilization by study participants. Direct
healthcare utilization will be extracted from patient records.
Patient Diaries will be completed at 3-month intervals from
randomization to end-of-follow-up, to gather retrospective
accounts of other health and social care utilization, out-of-
pocket expenses and productivity costs (Table 5). The SF-
36 will be completed at the same time points as the Patient
Diaries. The Patient Diaries will contain validated resource
utilization and productivity cost questionnaires such as
PRODISQ [134]. The primary outcome measure for the
cost effectiveness analysis will be the Quality Adjusted Life
Year (QALY). Utilities for the construction of QALYs will
be obtained from the SF-36 data using the SF-6D algo-
rithm [135]. As the time horizon for the analysis is less
than 12 months, discounting will not be required [138].
We will report the incremental cost per QALY gained for
the integrated intervention compared to usual prenatal
care. Uncertainty in the expected costs and outcomes for
the integrated intervention and usual prenatal care will be
characterized using the non-parametric bootstrap. The re-
sults of the bootstrap analysis will be used to construct
scatterplots on the cost effectiveness plane and cost-
effectiveness acceptability curves showing the probability
that the integrated intervention is a cost effective use of
healthcare resources for a range of values of health.
Qualitative descriptive study
Design
Incorporating participant perspectives and experiences to
assess the suitability and utility of interventions is critical in
trials of complex interventions in order to identify compo-
nents that may influence the outcomes [139]. Phase 2 uti-
lizes a qualitative descriptive study to assess women’s and
healthcare providers’ views on efficiency, utility, usability,
feasibility, acceptability, and potential mechanisms of action
of the intervention.
Methods
Participant eligibility and recruitment All interven-
tion group participants and healthcare providers workingat study sites are eligible for participation in Phase 2.
Purposeful sampling will be used to maximize variability
in the sample, ensuring that a broad range of views and
demographics are represented [140]. We plan to inter-
view 15 to 20 intervention group women and 8 to 10
providers (for example, nurses, family physicians) with
the final sample size determined by data saturation.
Given the importance of understanding factors contrib-
uting to attrition, we will also interview intervention
group women who do not complete all CBT modules. In
order to capture women who may not complete all six
modules, a notification at the end of each of the fourth,
fifth, and sixth CBT modules will invite women in the
intervention group to participate in a follow-up inter-
view. Selection of the affirmative response will generate
an automatic email to the research coordinator for
follow-up. Emails distributed by each of the clinic man-
agers will invite clinic staff members to participate in a
follow-up interview.
Data collection and management We will conduct in-
dividual face-to-face or telephone-based interviews.
Semi-structured interview guides will be used [140] to
ask participants their views on the efficiency, utility, us-
ability, feasibility, acceptability, and mechanisms of ac-
tion of the intervention (Table 3), as well as its
strengths, suggestions for improvement, components
that were effective/not effective, and the benefits that
they experienced. Interviews are expected to take one
hour and will be digitally recorded and transcribed ver-
batim. Transcribed interviews and digital files will be
password protected and stored on a password protected
computer in a secure, locked office. Digital files will be
stored for 5 years and then deleted. All data will be
anonymized for publication.
Analysis As recommended for qualitative descriptive
studies, we will use standard qualitative content analysis
approaches for thematic analysis of the transcripts [140].
Two members of the team experienced in qualitative
data analysis will independently code the first two or
three transcripts, discuss, and reach consensus on a pre-
liminary coding scheme. This coding scheme will be ap-
plied in the coding of another two to three transcripts,
following which the two researchers will discuss a re-
vised coding scheme. At this point, the coding scheme
will be sufficiently developed to allow one research team
member to independently code the remaining transcripts,
with revisions made as necessary to reflect new and evolv-
ing themes as data analysis progresses [140]. Thematic
analysis will occur concurrently with data collection to
allow further exploration and clarification of emergent
ideas, and data collection will continue until data satur-
ation is reached [141].
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The IMPACT: Pilot and IMPACT: RCT trials were funded
within a few months of each other. Recruitment for the
IMPACT: RCT has been deferred to February, 2014 to
permit collection of pilot data. The pilot and full RCT
share the same study design and methodology, with the
exception that the pilot study will collect data to 3 months
postpartum, and the full RCT will collect data to 12
months postpartum. The same recruitment sites will be
utilized for both the pilot and full RCT. Data from the
pilot trial will be used to refine the intervention, the eco-
nomic evaluation, and the logistics involved in the full
trial. At the time of manuscript submission, the CBT
modules and the online version of the psychosocial assess-
ment component (ANRQ-R and EPDS) are being finalized
and recruitment for IMPACT: Pilot will begin in Septem-
ber, 2013. Trial registration is through ClinicalTrials.gov
(Identifier: NCT01901796).
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